Eric Hyndman, MD, PhD

Contact

Department of Surgical Oncology
University of Calgary
Prostate Cancer Centre
Rockyview General Hospital
7007 14 ST SW
Calgary, Alberta, Canada
T2V 1P9
(403) 943-8910
erichyndman@shaw.ca
http://www.prostatecancercentre.ca

Urologist, Clinical Assistant Professor
University of Calgary, Prostate Cancer Centre, Calgary, AB

Dr. Eric Hyndman is a clinical assistant professor of urology who subspecializes in minimally invasive, robotic and open surgical treatment of urologic malignancies. He started his medical career the University of Calgary and obtained his PhD in medical sciences investigating cardiovascular genetics. He then completed his medical degree in Calgary after which he travelled north to Edmonton for his Urology residency. He then continued his studies by completing a fellowship at Johns Hopkins in Urologic Oncology. He is now an active Urologic Surgeon at the Southern Alberta Institute of Urology.

Dr. Hyndman also has an active and expanding research program investigating the both prostate and bladder cancers. In particular he leads the active surveillance program in Calgary and within this population is trying to determine what causes progression to an aggressive disease.


Relevant Publications

Kiril Trpkov, Hatem Abou-Ouf, Ondrej Hes, Jose I Lopez, Gabriella Nesi, Eva Comperat, Mathilde Sibony, Adeboye O Osunkoya, Ming Zhou, Neriman Gokden, Xavier Leroy, Daniel M Berney, Isabela Werneck Cunha, Maria L Musto, Daniel A Athanazio, Asli Yilmaz, Bryan Donnelly, Eric Hyndman, Anthony J Gill, Jesse K McKenney, Tarek A Bismar. Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphological and Molecular Characterization of ESC RCC as a Distinct Entity. AJSP 2017

Remondini Taylor, Van Zyl Stephan, Bismar Tarek A., Yilmaz Serdar, Hyndman M. Tubulovillous Adenoma in the Bladder in a Dual Pancreas-Kidney Transplant Patient. Journal of Endourology Case Reports. February 2017, 3(1): 17-20.

Falegan OS, Ball MW, Shaykhutdinov RA, Pieroraio PM, Farshidfar F, Vogel HJ, Allaf ME, Hyndman ME. Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma. Metabolites. 2017 Feb 3;7(1).

 Hiroaki Ishida, Katharine V. Jensen1, Andrew G. Woodman, M. Eric Hyndman, Hans J. Vogel. The Calcium-Dependent Switch Helix of L-Plastin Regulates Actin Bundling. Scientific Reports. 2016.

Arias M, Hilchie A, Haney E, Hancock R, Bolscher J, Hyndman ME, Vogel H. Anticancer activities of bovine and human lactoferricin-derived peptides. Accepted for publication Biochemistry and Cell Biology 2016.

Ghai S, Eure G, Fradet V, Hyndman ME, McGrath T, Wodlinger B, Pavlovich CP. Assessing Cancer Risk in Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the PRI-MUS (prostate risk identification using micro-ultrasound) protocol. J Urol. 2016 Jan 11.

Hyndman ME, Bivalacqua TJ , Feng Z, Mettee L, Su L, Trock BJ, Pavlovich CP. Nightly sildenafil use after radical prostatectomy has adverse effects on urinary convalescence: Results from a randomized trial of nightly vs on-demand dosing regimens. CUAJ. Nov. 2016

Kaye D, Hyndman ME, Segal R, Mettee L,  Trock B, Feng Z, Su L, Bivalacqua T,  Pavlovich C, Urinary outcomes are significantly affected by nerve-sparing quality during radical prostatectomy. Urology 2013 Oct 2. pii: S0090-4295(13)01040-6.

Hyndman ME, Kaye D, Field NC, Lawson KA, Smith ND, Steinberg GD, Schoenberg MP, Bivalacqua TJ. The use of regenerative medicine in the management of invasive bladder cancer. Adv Urol. 2012;2012:653652.

Sundi D, Tseng K, Mullins JK, Marr KA, Hyndman ME. Invasive fungal bezoar requiring partial cystectomy. Urology 2012 Feb;79(2).

Hyndman M.E. Mullins JK, Bivalacqua TJ. Metabolomics and Bladder Cancer. Urologic Oncology. 2011 Sep-Oct;29(5):558-61

Albadine R, Hyndman ME, Chaux A, Jeong JY, Saab S, Tavora F, Epstein JI, Gonzalgo ML, Pavlovich CP, Netto GJ. Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. Hum Pathol. 2012 Feb;43(2):254-60.

Mullins JK, Hyndman ME, Mettee LZ, Pavlovich CP. Comparison of Extraperitoneal and Transperitoneal Pelvic Lymph Node Dissection During Minimally Invasive Radical Prostatectomy. J Endourol. 2011 Sep-Oct;29(5):558-61.

Pierorazio PM, Lin BM, Mullins JK, Hyndman ME, Schaeffer EM, Han M, Partin AW, Pavlovich CP. Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy. Urol Oncol. 2013 Jul;31(5):589-94

Feng T, Yohannan J, Gupta A, Hyndman ME, Allaf M. Perforations and microperfortions of surgical gloves in urology after endoscopic, laparoscopic and open surgeries. Can J Urol. 2011 Apr;18(2):5615-8.

Lin BM, Hyndman ME,  Steele KE, Feng Z, Trock B, Schweitzer MA, Pavlovich CP. Incidence and risk factors for inguinal and incisional hernias after laparoscopic radical prostatectomy. Urology. 2011 Apr;77(4):957-62.

Eifler JB, Levinson AW, Hyndman ME, Trock BJ, Pavlovich CP.  Pelvic Lymph Node Dissection Is Associated with Symptomatic Venous Thromboembolism Risk During Laparoscopic Radical Prostatectomy. J Urol. 2011 May;185(5):1661-6.

Hyndman ME, Mulllins J, Pavlovich C. Pelvic node dissection in prostate cancer: extended, limited, or not at all?  Current opinion in Urology 2010 May; 20(3):211-7.

Anderson TJ, Sun YH, Hubacek J, Hyndman ME, Verma S, Shewchuk L, Scott-Douglas N.  Effects of folinic acid on forearm blood flow in patients with end-stage renal disease. Nephrol Dial Transplant. 2006 Jul;21(7):1927-33.

Hyndman ME, Manns BJ, Snyder FF, Bridge PJ, Scott-Douglas NW, Fung E, Parsons HG. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease. Metabolism 2003 52:168-172.

Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 2002 282:H2167-H2172.

Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, Anderson TJ. The T-786–>C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 2002 39:919-922.

Manns B, Hyndman E, Burgess E, Parsons H, Schaefer J, Snyder F, Scott-Douglas N. Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia. Kidney Int  2001 59:1103-1109.

Dumont AS, Hyndman ME, Dumont RJ, Fedak PM, Kassell NF, Sutherland GR, Verma S. Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin. J Neurosurg 2001 95:466-471.

Hyndman ME, Bridge PJ, Warnica JW, Fick G, Parsons HG. Effect of heterozygosity for the methionine synthase 2756 A–>G mutation on the risk for recurrent cardiovascular events. Am J Cardiol 2000 86:1144-6, A9.

Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. 1999 Am J Kidney Dis 34:669-677.

Manns BJ, Burgess ED, Parsons HG, Schaefer JP, Hyndman ME, Scott-Douglas NW. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. 1999 Kidney Int 55:315-320.

Dias VC, Bamforth FJ, Tesanovic M, Hyndman ME, Parsons HG, Cembrowski GS. Evaluation and intermethod comparison of the Bio-Rad high-performance liquid chromatographic method for plasma total homocysteine. 1998 Clin Chem 44:2199-2201.

Academic Guest Editor:

Sai-Wen Tang and Jung-Yaw Lin. Full Length Enrich c-DNA Libraries-clear cell-Renal Cell Carcinoma. Journal of Oncology. In press.

Book Chapters:

Handbook of Urology: Editors: J. Kellog Parsons, John Eifler and Misop Han, Wiley-Blackwell; Chapter 22  Penile and Urethral Cancer-Mathew Hyndman

Contact

Department of Surgical Oncology
University of Calgary
Prostate Cancer Centre
Rockyview General Hospital
7007 14 ST SW
Calgary, Alberta, Canada
T2V 1P9
(403) 943-8910
erichyndman@shaw.ca
http://www.prostatecancercentre.ca